zidovudine has been researched along with Cancer of Skin in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.00) | 18.7374 |
1990's | 16 (64.00) | 18.2507 |
2000's | 2 (8.00) | 29.6817 |
2010's | 4 (16.00) | 24.3611 |
2020's | 1 (4.00) | 2.80 |
Authors | Studies |
---|---|
Agostini, A; Avallone, G; Calcagno, A; Caracciolo, D; Fierro, MT; Mastorino, L; Merli, M; Quaglino, P; Ribero, S; Rubatto, M; Senetta, R; Trunfio, M | 1 |
Chandrasekar, S; Idris, MM; Kavitha, M; Mahesh Kumar, J; Mainkar, PS; Meghah, V; Nagesh, N; Pal, B; Reddy, CR; Srinivas, G; Vinay Kumar, P | 1 |
Ferko, B; Humer, J; Muster, T; Pehamberger, H; Rapberger, R; Waltenberger, A | 1 |
Bittencourt, AL; Farré, L; Mota, K; Oliveira, RF | 1 |
Grubb, B; Henderson, DB; Pandya, AG | 1 |
Ferreira, LM; Gragnani, A; Lipay, MV; Oliveira, AF; Santos, ID; Souza Sobrinho, CP | 1 |
Garbe, C; Husak, R; Orfanos, CE; Wölfer, U | 1 |
Jablonowski, H; Mauss, S | 1 |
Baron, P; Polsky, B; Prochaska, HJ; Yeh, Y | 1 |
Bolao, F; Casanova, A; Clotet, B; García, P; Gudiol, F; Pagerols, X; Podzamczer, D | 1 |
Ajisawa, A; Akagi, K; Masuda, G; Negishi, M; Sekido, N | 1 |
Bruce, S; Dupuy, J; Lynch, G; Price, M; Schwartz, M | 1 |
Chmiel, JS; Hoover, DR; Jacobson, LP; Joffe, MM; Kingsley, L; Robins, JM; Visscher, BR | 1 |
Anderson, LM; Diwan, BA; Haines, DC; Logsdon, D; Olivero, OA; Poirier, MC; Rice, JM; Yuspa, SH; Zhang, Z | 1 |
Corazza, M; Lombardi, AR; Sighinolfi, L; Virgili, A | 1 |
Dallenbach, F; Detmar, M; Garbe, C; Orfanos, CE; Reupke, H; Schröder, K; Waibel, M | 1 |
Causse, X; Chevallier, M; Gaudin, JL; Trépo, C; Zoulim, F | 1 |
Berger, TG; Kahn, JO; Kaplan, LD; Tappero, JW; Volberding, PA | 1 |
Baumann, R; Chave, JP; Hirschel, B; Kinloch, S; Lüthy, R; Opravil, M; Pletscher, M; Täuber, MG | 1 |
Barnett, JH; Gilson, I | 1 |
Bratzke, B; Orfanos, CE; Ruszczak, Z; Stadler, R | 1 |
Krown, SE | 1 |
Rasokat, H | 1 |
Beall, G; Trivedi, D | 1 |
5 review(s) available for zidovudine and Cancer of Skin
Article | Year |
---|---|
Kaposi's sarcoma: a reevaluation.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Comorbidity; Follow-Up Studies; Germany; Homosexuality, Male; Humans; Immunocompromised Host; Immunologic Factors; Interferon Type I; Male; Palliative Care; Prognosis; Recombinant Proteins; Risk; Sarcoma, Kaposi; Skin Diseases; Skin Neoplasms; Survival Analysis; Viscera; Zidovudine | 1995 |
Estimating the effect of zidovudine on Kaposi's sarcoma from observational data using a rank preserving structural failure-time model.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bisexuality; Cohort Studies; Homosexuality, Male; Humans; Male; Models, Statistical; Regression Analysis; Risk; Sarcoma, Kaposi; Skin Neoplasms; Treatment Failure; Treatment Outcome; Zidovudine | 1998 |
Approaches to interferon combination therapy in the treatment of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Interferon Type I; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Zidovudine | 1990 |
[Therapeutic possibilities in HIV infection and AIDS].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Humans; Immunotherapy; Opportunistic Infections; Sarcoma, Kaposi; Skin Diseases; Skin Diseases, Infectious; Skin Neoplasms; Zidovudine | 1989 |
Ambulatory care of patients infected with the human immunodeficiency virus (HIV).
Topics: Acquired Immunodeficiency Syndrome; Humans; Opportunistic Infections; Sarcoma, Kaposi; Skin Neoplasms; Zidovudine | 1989 |
5 trial(s) available for zidovudine and Cancer of Skin
Article | Year |
---|---|
Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Core Protein p24; Humans; Interferon alpha-2; Interferon-alpha; Lymphocyte Subsets; Male; Palatal Neoplasms; Prognosis; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms; Zidovudine | 1993 |
Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Zidovudine | 1993 |
Estimating the effect of zidovudine on Kaposi's sarcoma from observational data using a rank preserving structural failure-time model.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bisexuality; Cohort Studies; Homosexuality, Male; Humans; Male; Models, Statistical; Regression Analysis; Risk; Sarcoma, Kaposi; Skin Neoplasms; Treatment Failure; Treatment Outcome; Zidovudine | 1998 |
Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Cryosurgery; Drug Evaluation; Follow-Up Studies; Humans; Sarcoma, Kaposi; Skin; Skin Neoplasms; Zidovudine | 1991 |
Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
Topics: Administration, Oral; Adult; CD4 Antigens; Combined Modality Therapy; Dose-Response Relationship, Drug; Follow-Up Studies; Gene Products, gag; HIV Core Protein p24; HIV Infections; Humans; Injections, Subcutaneous; Interferon Type I; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Viral Core Proteins; Zidovudine | 1991 |
16 other study(ies) available for zidovudine and Cancer of Skin
Article | Year |
---|---|
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Human T-lymphotropic virus 1; Humans; Interferon alpha-2; Italy; Leukemia-Lymphoma, Adult T-Cell; Male; Nigeria; Skin Neoplasms; Zidovudine | 2021 |
Phenyl 1,2,3-triazole-thymidine ligands stabilize G-quadruplex DNA, inhibit DNA synthesis and potentially reduce tumor cell proliferation over 3'-azido deoxythymidine.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Click Chemistry; DNA Fragmentation; DNA, Neoplasm; G-Quadruplexes; Humans; Ligands; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Skin Neoplasms; Thymidine; Triazoles; Tumor Burden; Zidovudine | 2013 |
Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Humans; Melanoma; Mice; Mice, SCID; Neoplasm Transplantation; Random Allocation; S Phase; Skin Neoplasms; Zidovudine | 2008 |
A dyshidrosis-like variant of adult T-cell leukemia/lymphoma with clinicopathological aspects of mycosis fungoides. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diabetes Mellitus; Diagnosis, Differential; Doxorubicin; Eczema, Dyshidrotic; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunohistochemistry; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Mycosis Fungoides; Polymerase Chain Reaction; Prednisone; Skin Neoplasms; Vincristine; Zidovudine | 2009 |
Adult T-cell lymphoma/leukemia presenting as pagetoid reticulosis of the palms and soles.
Topics: Adult; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Foot; Hand; Humans; Interferons; Jamaica; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Pagetoid Reticulosis; Prednisone; Skin Neoplasms; Vincristine; Zidovudine | 2011 |
AZT on telomerase activity and cell proliferation in HS 839.T melanoma cells.
Topics: Adult; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Skin Neoplasms; Telomerase; Time Factors; Zidovudine | 2012 |
Toxicology and carcinogenesis studies of mixtures of 3'-azido-3'-deoxythymidine (AZT), lamivudine (3TC), nevirapine (NVP), and nelfinavir mesylate (NFV) (Cas Nos. 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (transplacental exposure s
Topics: Administration, Oral; Animals; Anti-Retroviral Agents; DNA; Drug Therapy, Combination; Escherichia coli; Female; Lamivudine; Longevity; Male; Maternal Exposure; Mice; Mice, Inbred Strains; Nelfinavir; Nevirapine; Pregnancy; Prenatal Exposure Delayed Effects; Salmonella typhimurium; Skin Neoplasms; Zidovudine | 2013 |
Efficacy, safety, and tolerance of low-dose, long-term interferon-alpha 2b and zidovudine in early-stage AIDS-associated Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Gastrointestinal Neoplasms; Humans; Interferon alpha-2; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Palatal Neoplasms; Pilot Projects; Prospective Studies; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Zidovudine | 1995 |
Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Glutathione; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphoma, T-Cell, Cutaneous; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Pyrazines; Reverse Transcriptase Inhibitors; Skin Neoplasms; Thiones; Thiophenes; Time Factors; Tumor Cells, Cultured; Virus Replication; Zidovudine | 1993 |
[Kaposi's sarcoma in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Female; Gastrointestinal Neoplasms; Humans; Interferon-alpha; Male; Radiotherapy Dosage; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine; Zidovudine | 1993 |
Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.
Topics: Animals; Anti-HIV Agents; Female; Genes, ras; Liver Neoplasms; Lung Neoplasms; Mice; Mutation; Pregnancy; Prenatal Exposure Delayed Effects; Skin Neoplasms; Zidovudine | 1998 |
Cutaneous ulcers due to interferon seem not to be related to the dosage.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Skin Ulcer; Zidovudine | 1999 |
[Granulocyte colony stimulating factor (G-CSF) in treatment of patients with HIV-associated mucocutaneous Kaposi sarcoma. Successful use in virus and drug-induced leukopenia].
Topics: Adult; Combined Modality Therapy; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Injections, Subcutaneous; Leukocyte Count; Leukopenia; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Sarcoma, Kaposi; Skin; Skin Neoplasms; Zidovudine | 1992 |
[Recovery of chronic hepatitis B- delta infection by zidovudine and recombinant interferon alpha combination therapy in a patient with Kaposi's sarcoma associated with HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Therapy, Combination; Hepatitis B; Hepatitis D; Humans; Interferon Type I; Male; Opportunistic Infections; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Zidovudine | 1992 |
Zidovudine-related thrombocytopenia simulating rapid growth of Kaposi's sarcoma.
Topics: Adult; HIV Seropositivity; Humans; Male; Mouth Neoplasms; Purpura; Sarcoma, Kaposi; Skin Neoplasms; Thrombocytopenia; Zidovudine | 1991 |
[Varied behavior of Kaposi sarcomas].
Topics: Adult; Combined Modality Therapy; HIV Infections; Humans; Interferon Type I; Male; Neoplasms, Multiple Primary; Prognosis; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Zidovudine | 1990 |